Financials

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 19,423 $ 13,724
Investments 139,939 7,182
Restricted cash 285 192
Prepaid expenses and other current assets 1,243 2,448
Total current assets 160,890 23,546
Restricted cash 385 478
Property and equipment, net 519 973
Operating lease right of use assets 2,377 3,063
Other assets 0 212
Total assets 164,171 28,272
Current liabilities:    
Notes payable 0 301
Accounts payable 2,887 3,179
Accrued expenses 7,176 11,030
Derivative liability 0 39
Operating lease liabilities, current 1,562 1,437
Loan payable 0 15,908
Total current liabilities 11,625 31,894
Other long-term liabilities 0 44
Operating lease liabilities, noncurrent 2,048 3,239
Total liabilities 13,673 35,177
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at September 30, 2024 and December 31, 2023. 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized,12,179,482 and 4,423,683 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 1 0
Additional paid-in capital 617,653 429,780
Accumulated deficit (467,363) (436,684)
Accumulated other comprehensive gain (loss) 207 (1)
Total stockholders equity (deficit) 150,498 (6,905)
Total liabilities and stockholders’ equity $ 164,171 $ 28,272

Source

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 10,808 $ 6,551 $ 23,435 $ 24,188
General and administrative 4,697 2,937 12,681 10,786
Total operating expenses 15,505 9,488 36,116 34,974
Operating loss (15,505) (9,488) (36,116) (34,974)
Other income (expense), net:        
Other income, net 713 218 4,317 630
Interest income 1,189 217 2,757 711
Interest expense (381) (980) (1,872) (2,928)
Change in fair value of derivative liability 0 0 39 0
Foreign currency transaction gain (loss), net 201 (20) 196 (21)
Other income (expense), net 1,722 (565) 5,437 (1,608)
Net loss $ (13,783) $ (10,053) $ (30,679) $ (36,582)
Net loss per share, basic $ (1.15) $ (2.27) $ (2.92) $ (8.52)
Net loss per share, diluted $ (1.15) $ (2.27) $ (2.92) $ (8.52)
Weighted average number of common shares outstanding, basic 12,014,700 4,423,617 10,490,981 4,295,178
Weighted average number of common shares outstanding, diluted 12,014,700 4,423,617 10,490,981 4,295,178
Comprehensive loss:        
Net Income (Loss) $ (13,783) $ (10,053) $ (30,679) $ (36,582)
Other comprehensive (loss) income :        
Change in unrealized (loss) gain on marketable debt securities 595 16 208 119
Total other comprehensive (loss) income 595 16 208 119
Total comprehensive loss $ (13,188) $ (10,037) $ (30,471) $ (36,463)

Source

v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (30,679) $ (36,582)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 4,513 2,671
Depreciation expense 454 493
Net amortization on discount of investments (2,500) (426)
Amortization of debt discount 396 634
Other (10) 13
Changes in operating assets and liabilities:    
Decrease (increase) in prepaid expenses and other current assets 1,129 (1,377)
Decrease (increase) in other assets 212 (46)
Decrease in operating lease right of use asset 686 606
(Decrease) increase in other long-term liabilities (44) 797
(Decrease) increase in accounts payable (75) 2,527
(Decrease) increase in accrued expenses (3,868) 1,547
Decrease in operating lease liabilities (1,066) (949)
Net cash used in operating activities (30,852) (30,092)
Cash flows from investing activities:    
Purchases of investments (169,563) (30,556)
Proceeds from sales and maturities of investments 39,523 55,810
Net cash (used in) provided by investing activities (130,040) 25,254
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 182,071 127
Repayment of notes payable (301) (353)
Repayment of long-term borrowings (15,179) (690)
Net cash provided by (used in) financing activities 166,591 (916)
Net increase (decrease) in cash, cash equivalents, and restricted cash 5,699 (5,754)
Cash, cash equivalents, and restricted cash at beginning of the period 14,394 17,673
Cash, cash equivalents, and restricted cash at end of the period 20,093 11,919
Supplemental disclosure of cash flow information and non-cash transactions:    
Cash paid during the period for interest 2,818 1,986
Write off of fully depreciated property and equipment 0 178
Common stock issuance costs not yet paid 75 0
Issuance of common stock for conversion of convertible debt $ 1,125 $ 875

Source